» Articles » PMID: 20410068

Clinical Burden of Erosive Hand Osteoarthritis and Its Relationship to Nodes

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2010 Apr 23
PMID 20410068
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the clinical burden of erosive osteoarthritis (EOA) of the hand in terms of pain, functioning and health-related quality of life (HRQL) and its relationship to nodal osteoarthritis (OA).

Methods: Patients with EOA (n=42) and non-EOA (n=194) of the hand were compared. Pain was assessed with the Australian/Canadian Osteoarthritis Hand Index (AUSCAN), the Michigan Hand Outcome Questionnaire (MHQ) and pain intensity upon pressure. Functioning was evaluated with AUSCAN, MHQ, grip strength, pinch grip and hand mobility tests. HRQL was measured with the Short Form-36. Patient satisfaction with hand function and aesthetics were also evaluated. The presence of nodal OA as well as its extent (reflected by the number of nodes) was assessed. Mean differences between patient groups were estimated with linear mixed models. To determine whether differences were independent of the nodal character of the disease, adjustments were made for the number of nodes.

Results: Patients with EOA experienced more pain, more functional limitation, less satisfaction with hand function and aesthetics and worse hand mobility than patients with non-EOA. HRQL was similar for the two groups. Patients with EOA had more nodes. A higher number of nodes was associated with worse outcome. After correction for the number of nodes, only hand mobility and patient satisfaction remained different between the groups.

Conclusion: Patients with EOA have a higher clinical burden than those with non-erosive disease. This higher burden is only partly attributed to the erosive disease itself, but mainly to the nodal character of the disease.

Citing Articles

Metabolic syndrome is not associated with erosive hand osteoarthritis: a cross-sectional study using data from the PROCOAC cohort.

Silva-Diaz M, Pertega-Diaz S, Balboa-Barreiro V, Tilve-Alvarez C, Raga-Sivira A, Rego-Perez I Sci Rep. 2024; 14(1):5968.

PMID: 38472231 PMC: 10933413. DOI: 10.1038/s41598-024-55374-1.


RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial.

Wittoek R, Verbruggen G, Vanhaverbeke T, Colman R, Elewaut D Nat Med. 2024; 30(3):829-836.

PMID: 38361122 PMC: 10957468. DOI: 10.1038/s41591-024-02822-0.


Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results from a 6-month observational retrospective study.

Tenti S, Veronese N, Cheleschi S, Seccafico I, Bruyere O, Reginster J Aging Clin Exp Res. 2022; 34(7):1613-1625.

PMID: 35637324 PMC: 9246990. DOI: 10.1007/s40520-022-02151-7.


Transcutaneous vagus nerve stimulation in erosive hand osteoarthritis: protocol for the randomised, double-blind, sham-controlled ESTIVAL trial.

Courties A, Deprouw C, Rousseau A, Berard L, Touati A, Kalsch J BMJ Open. 2022; 12(3):e056169.

PMID: 35318234 PMC: 8943744. DOI: 10.1136/bmjopen-2021-056169.


Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot Trial.

Courties A, Deprouw C, Maheu E, Gibert E, Gottenberg J, Champey J J Clin Med. 2022; 11(4).

PMID: 35207369 PMC: 8878516. DOI: 10.3390/jcm11041087.